Salutogenic Approach Based Interview With People With Schizophrenia
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04740944 |
|
Recruitment Status :
Completed
First Posted : February 5, 2021
Last Update Posted : February 5, 2021
|
- Study Details
- Tabular View
- Results Submitted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Salutogenesis Mental Health Disorder Schizophrenia Sense of Coherence | Behavioral: Salutogenic Approach Based Interview | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 49 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Health Services Research |
| Official Title: | The Effect of Salutogenic Approach Based Interview on Sense of Coherence and Psychological Resistance of People With Schizophrenia: A Randomized Controlled Trial |
| Actual Study Start Date : | December 31, 2018 |
| Actual Primary Completion Date : | November 28, 2019 |
| Actual Study Completion Date : | December 31, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Intervention group
the intervention group was subjected to salutogenic approach-based interview consisting of 16 sessions twice a week.
|
Behavioral: Salutogenic Approach Based Interview
Salutogenic Approach Based Interview has five basic components. (1) Continuity of health, (2) The story of the person, (3) Health promoting factors, (4) Understanding the health promoting power of tension and strain, (5) Active adaptation In traditional therapy recommended for recovery, more emphasis is placed on negative life events, diagnosis and medication. In the salutogenic approach-based interview, the resources and coping potential of the person are discussed and three healing factors are focused on for the recovery process. These factors are that the participants (1) perceive themselves as more than just a diagnosis and disease, (2) self-discovery and respect for other people's self-discovery, (3) control over their own lives. In the intervention, mental health nurses take part as group leaders. The focus in interviews is therapeutic conversations. |
|
No Intervention: Control group
The control group continued their routine activities and was interviewed face-to-face 5 times.
|
- Sense of Coherence Scale_13 (SOC_13) [ Time Frame: 8 weeks ]At the end of 8 weeks (16 sessions of salutogenic approach based interview ), they were evaluated using the sense of coherence scale which was developed by Antonovsky (1987) is a self-report scale consisting of a total of 13 items ranging between 1 and 7. The scale allows to use subscale scores and calculate total score. Higher scale scores indicate that individual has higher sense of coherence. In the reliability studies of the original version of the scale, internal consistency coefficients were calculated as .62 for "meaningfulness", .54 for "manageability", .57 for "comprehensibility", and .69 for overall scale.
- Brief Resilience Scale (BRS) [ Time Frame: 8 weeks ]At the end of 8 weeks (16 sessions of salutogenic approach based interview ), they were evaluated using brief resilience scale which was developed by Smith et al., (2008) to measure resilience of individuals. The scale is a 5-point likert self-report assessment instrument with 6 items. High BRS scores signify higher resilience of a person.
- Sense of Coherence Scale_13 (SOC_13) [ Time Frame: 12 weeks ]At the end of 12 weeks (16 sessions of salutogenic approach based interview + 1 month), they were evaluated using the sense of coherence scale which was developed by Antonovsky (1987) is a self-report scale consisting of a total of 13 items ranging between 1 and 7. The scale allows to use subscale scores and calculate total score. Higher scale scores indicate that individual has higher sense of coherence. In the reliability studies of the original version of the scale, internal consistency coefficients were calculated as .62 for "meaningfulness", .54 for "manageability", .57 for "comprehensibility", and .69 for overall scale.
- Brief Resilience Scale (BRS) [ Time Frame: 12 weeks ]At the end of 8 weeks (16 sessions of salutogenic approach based interview ), they were evaluated using brief resilience scale which was developed by Smith et al., (2008) to measure resilience of individuals. The scale is a 5-point likert self-report assessment instrument with 6 items. High BRS scores signify higher resilience of a person.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion criteria of the study:
- Getting diagnosed with schizophrenia or schizoaffective disorder
- Completing acute treatment and being at maintenance medication period
Exclusion criteria of the study
- Being at the period of psychotic relapse
- Having mental development disorder
- Being under the influence of alcohol-drugs
- Having diagnosed with personal disorder
- Being considered unsuitable to include in the group study by doctors and nurses of CMHC.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04740944
| Turkey | |
| Istanbul University - Cerrahpasa Institute of Granduate Studies | |
| Istanbul, Turkey | |
| Principal Investigator: | OZGUR S ACI, Dr | Istanbul University-Cerrahpasa |
Publications of Results:
Other Publications:
| Responsible Party: | Özgür Sema ACI, Dr, Istanbul University-Cerrahpasa |
| ClinicalTrials.gov Identifier: | NCT04740944 |
| Other Study ID Numbers: |
Nurse_Psychiatric |
| First Posted: | February 5, 2021 Key Record Dates |
| Last Update Posted: | February 5, 2021 |
| Last Verified: | February 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Plan Description: | There is no plan to share to IPD |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Salutogenesis sense of coherence resilience schizophrenia |
|
Schizophrenia Mental Disorders Schizophrenia Spectrum and Other Psychotic Disorders |

